Epidemiological characteristics and trends of Bacillus Calmette–Guérin lymphadenitis in Shanghai, China from 2010 to 2019

References

• The World Health Organization. BCG vaccines: WHO position paper. Weekly Epidemiological Rec 2018;93:73–6.
   PubMedGoogle Scholar
• Xia XZ, Luo HM. Practical vaccination manual. Beijing (China): People’s Health Press; 2010.
   Google Scholar
• Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, Rodrigues LC, Smith PG, Lipman M, Whiting PF, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis. 2014;58:470–80. doi:10.1093/cid/cit790.
   PubMed Web of Science ®Google Scholar
• Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. 2006;367:1173–80. doi:10.1016/S0140-6736(06)68507-3.
   PubMed Web of Science ®Google Scholar
• Goraya JS, Virdi VS. Bacille Calmette-Guerin lymphadenitis. Postgrad Med J. 2002;78:327–29. doi:10.1136/pmj.78.920.327.
   PubMed Web of Science ®Google Scholar
• Norouzi S, Aghamohammadi A, Mamishi S, Rosenzweig SD, Rezaei N. Bacillus Calmette-Guerin (BCG) complications associated with primary immunodeficiency diseases. J Infect. 2012;64:543–54. doi:10.1016/j.jinf.2012.03.012.
   PubMed Web of Science ®Google Scholar
• Li KL, Liu DW, Wu WD, Xu DS, Zhen JS, Cao LS, Cao L, Yuan P, Wang HQ. Analysis on surveillance of adverse events following immunization for Bacille Calmette-Guerin vaccine in China, 2009-2010. Chin J Vacc Immunization. 2012;18:252–60.
   Google Scholar
• Wu WD, Liu DW, Li L. Literature review of adverse events following immunization of Bacillus Calemtte-Guerin vaccine. Zhongguo Yi Miao He Mian Yi. 2009;15:491–95.
   PubMedGoogle Scholar
• Kuchukhidze G, Kasradze A, Dolakidze T, Baliashvili D, Merabishvili T, Blumberg HM, Kempker RR. Increase in lymphadenitis cases after shift in BCG vaccine strain. Emerg Infect Dis. 2015;21:1677–79. doi:10.3201/2109.150289.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51. doi:10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z.
   PubMed Web of Science ®Google Scholar
• Rermruay R, Rungmaitree S, Chatpornvorarux S, Brukesawan C, Wittawatmongkol O, Lapphra K, Phongsamart W, Kongstan N, Khumcha B, Chokephaibulkit K. Clinical features and outcomes of Bacille Calmette-Guerin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization. Vaccine. 2018;36:4046–53. doi:10.1016/j.vaccine.2018.05.098.
   PubMed Web of Science ®Google Scholar
• Roh EJ, Lee YK, Lee MH, Kim MK, Kim TE, Lee SG, Chung EH. Investigation of adverse events following bacille Calmette-Guerin immunization using immunization safety surveillance system in Korea Centers for Disease Control and Prevention. Clin Exp Vaccine Res. 2020;9:133–45. doi:10.7774/cevr.2020.9.2.133.
   PubMed Web of Science ®Google Scholar
• Mahmoudi S, Khaheshi S, Pourakbari B, Aghamohammadi A, Keshavarz Valian S, Bahador A, Sabouni F, Ramezani A, Mamishi S. Adverse reactions to Mycobacterium bovis bacille Calmette-Guerin vaccination against tuberculosis in Iranian children. Clin Exp Vaccine Res. 2015;4:195–99. doi:10.7774/cevr.2015.4.2.195.
   PubMedGoogle Scholar
• Venkataraman A, Yusuff M, Liebeschuetz S, Riddell A, Prendergast AJ. Management and outcome of Bacille Calmette-Guerin vaccine adverse reactions. Vaccine. 2015;33:5470–74. doi:10.1016/j.vaccine.2015.07.103.
   PubMed Web of Science ®Google Scholar
• Daoud W. Control of an outbreak of BCG complications in Gaza. Respirology. 2003;8:376–78. doi:10.1046/j.1440-1843.2003.00489.x.
   PubMed Web of Science ®Google Scholar
• Barari-Savadkouhi R, Shour A, Masrour-Roudsari J. A study of the incidence of BCG vaccine complications in infants of Babol, Mazandaran (2011-2013). Caspian J Internal Med. 2016;7:48–51.
   PubMedGoogle Scholar
• Engelis A, Kakar M, Meiksans R, Petersons A. BCG-SSI((R)) vaccine-associated lymphadenitis: incidence and management. Medicina. 2016;52:187–91. doi:10.1016/j.medici.2016.05.001.
   PubMed Web of Science ®Google Scholar
• Dommergues MA, de La Rocque F, Guy C, Lecuyer A, Jacquet A, Guerin N, Fagot JP, Boucherat M, d’Athis P, Cohen R. Local and regional adverse reactions to BCG-SSI vaccination: a 12-month cohort follow-up study. Vaccine. 2009;27:6967–73. doi:10.1016/j.vaccine.2009.09.073.
   PubMed Web of Science ®Google Scholar
• Shanghai Municipal Health Commission. Shanghai guidelines on vaccination work. 2017 ed. Shanghai; 2017.
   Google Scholar
• Liu EY, Zhou L, Zhao SY, Li HM. The effects and adverse reactions of Bacillus Calmette-Guérin. Chin J Pract Pediatr. 2016;31:347–49.
   Google Scholar
• Riordan A, Cole T, Broomfield C. Fifteen-minute consultation: bacillus Calmette-Guerin abscess and lymphadenitis. Arch Dis Child Educ Pract Ed. 2014;99:87–89. doi:10.1136/archdischild-2013-304457.
   PubMed Web of Science ®Google Scholar
• Cuello-Garcia CA, Perez-Gaxiola G, Jimenez Gutierrez C. Treating BCG-induced disease in children. The Cochrane Database of Systematic Reviews. 2013;CD008300. doi:10.1002/14651858.CD008300.pub2.
   PubMed Web of Science ®Google Scholar
• Banani SA, Alborzi A. Needle aspiration for suppurative post-BCG adenitis. Arch Dis Child. 1994;71:446–47. doi:10.1136/adc.71.5.446.
   PubMed Web of Science ®Google Scholar
• Wondwossen A, Waqtola C, Gemeda A. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: a cohort study. Int J Mycobacteriol. 2016;5:14–20. doi:10.1016/j.ijmyco.2015.10.002.
   PubMed Web of Science ®Google Scholar
• Huang W, Chiu NC, Chi H, Huang FY, Huang CY. Inoculation age of Bacillus Calmette-Guerin Tokyo-172 strain and vaccine-related adverse reactions in Taiwan birth cohort of 2012-2017. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa1235.
   Web of Science ®Google Scholar
• Soh SB, Han PY, Tam KT, Yung CF, Liew WK, Tan NW, Chong CY, Thoon KC. Investigations into an outbreak of suppurative lymphadenitis with BCG vaccine SSI((R)) in Singapore. Vaccine. 2014;32:5809–15. doi:10.1016/j.vaccine.2014.08.032.
   PubMed Web of Science ®Google Scholar
• Alrabiaah AA, Alsubaie SS, Bukhari EI, Gad A, Alzamel FA. Outbreak of Bacille Calmette-Guerin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine. Ann Saudi Med. 2012;32:4–8. doi:10.5144/0256-4947.2012.4.
   PubMed Web of Science ®Google Scholar
• Lam TS, Leung YH, Tsang HL, Choi KW, Wong TY, Wong MH, Chuang SK. Bacille-Calmette-Guerin vaccine-associated suppurative lymphadenitis in Hong Kong Special Administrative Region (China), 2004 to 2012. West Pac Surveillance Response J. 2013;4:39–40. doi:10.5365/wpsar.2013.4.1.001.
   PubMedGoogle Scholar
• Thoon KC, Soh SB, Liew WK, Gunachandran A, Tan NW, Chong CY, Yung CF. Active surveillance of adverse events following childhood immunization in Singapore. Vaccine. 2014;32:5000–05. doi:10.1016/j.vaccine.2014.07.020.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Wu QS, Huang Q. Application of health care failure mode and effact analysis in BCG inoculation process of the newborn. Nurs J Chin PLA. 2017;34:61–64.
   Google Scholar